Showing results (321-330 of 350) with videos related to
Sort By:
Pageof 35
Circulation Research|May 30, 2009
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradationSabine Meurer, Sylke Pioch, Tatjana Pabst, et al.Nature|March 10, 2001
NO-independent regulatory site on soluble guanylate cyclaseJ P Stasch, E M Becker, C Alonso-Alija, et al.Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthmaArnab Ghosh, Cynthia J Koziol-White, Kewal Asosingh, et al.British Journal of Pharmacology|October 16, 2007
Cardiovascular effects of a novel potent and highly selective azaindole-based inhibitor of Rho-kinaseR Kast, H Schirok, S Figueroa-Pérez, et al.Chemmedchem|March 6, 2009
Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertensionJoachim Mittendorf, Stefan Weigand, Cristina Alonso-Alija, et al.Antioxidants & Redox Signaling|May 24, 2013
Direct sGC activation bypasses NO scavenging reactions of intravascular free oxy-hemoglobin and limits vasoconstrictionNicolaas J H Raat, D Marcela Tabima, Patricia A C Specht, et al.The European Respiratory Journal|June 14, 2008
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertensionR T Schermuly, J-P Stasch, S S Pullamsetti, et al.Nature Medicine|March 2, 2010
Kynurenine is an endothelium-derived relaxing factor produced during inflammationYutang Wang, Hanzhong Liu, Gavin McKenzie, et al.American Journal of Respiratory and Critical Care Medicine|September 18, 2007
Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilationOleg V Evgenov, Daniel S Kohane, Kenneth D Bloch, et al.Chemmedchem|November 1, 2008
Design and synthesis of potent and selective azaindole-based Rho kinase (ROCK) inhibitorsHartmut Schirok, Raimund Kast, Santiago Figueroa-Pérez, et al.Pageof 35